期刊文献+

熊去氧胆酸的作用机制及在肝移植中的应用 被引量:12

下载PDF
导出
摘要 熊去氧胆酸(UDCA)可有效治疗多种胆汁淤积性肝病,主要作用机制包括:(1)取代内源性疏水性胆汁酸成为总胆汁酸池的主要成分;(2)促进肝脏分泌和排泄胆汁酸盐;(3)直接保护肝细胞,拮抗疏水性胆汁酸引起的细胞损害和凋亡;(4)免疫调节作用,抑制肝内自身免疫反应。UDCA在肝移植中应用效果存在争议。部分研究发现UDCA可明显改善移植肝功能,并有辅助预防肝移植后急性排斥反应的作用,另有研究却得出相反的结论,迄今未能统一。
出处 《临床外科杂志》 2008年第3期201-202,共2页 Journal of Clinical Surgery
  • 相关文献

参考文献1

二级参考文献71

  • 1[1]Trauner M,Meier PJ,Boyer JL.Molecular pathogenesis of cholestasis.N Engl J Med 1998; 339:1217-1227
  • 2[2]Kullak-Ublick GA,Beuers U,Paumgartner G.Hepatobiliary transport.J Hepatol 2000; 32:3-18
  • 3[3]Kullak-Ublick GA,Stieger B,Meier PJ.Enterohepatic bile salt transporters in normal physiology and liver disease.Gastroenterology 2004; 126:322-342
  • 4[4]Nathanson MH,Boyer JL.Mechanisms and regulation of bile secretion.Hepatology 1991; 14:551-566
  • 5[5]Rius M,Nies AT,Hummel-Eisenbeiss J,Jedlitschky G,Keppler D.Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.Hepatology 2003; 38:374-384
  • 6[6]Bohan A,Chen WS,Denson LA,Held MA,Boyer JL.Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.J Biol Chem 2003; 278:36688-36698
  • 7[7]Ballatori N,Christian WV,Lee JY,Dawson PA,Soroka CJ,Boyer JL,Madejczyk MS,Li N.OSTalpha-OSTbeta:a major basolateral bile acid and steroid transporter in human intestinal,renal,and biliary epithelia.Hepatology 2005; 42:1270-1279
  • 8[8]Trauner M,Wagner M,Fickert P,Zollner G.Molecular regulation of hepatobiliary transport systems:clinical implications for understanding and treating cholestasis.J Clin Gastroenterol 2005; 39:S111-124
  • 9[9]Soroka C,Zollner G,Mennone A,Ballatori N,Trauner M,Boyer JL.The heteromeric organic solute transporter,OST alpha-OST beta,is up-regulated in the liver of patients with primary biliary cirrhosis (PBC) and variably induced in rat and mouse cholangiocytes following bile duct ligation.Hepatology 2005; 42:414A
  • 10[10]Paumgartner G,Beuers U.Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.Clin Liver Dis 2004; 8:67-81,vi

共引文献12

同被引文献116

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部